Semisynthesis and pharmacological activities of tetrac analogs: Angiogenesis modulators

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/23162

Title:	Semisynthesis and pharmacological activities of tetrac analogs: Angiogenesis modulators
Authors:	Bridoux, Alexandre Cui, Huadong Dyskin, Evgeny A. Mousa, Shaker A. Uludağ Üniversitesi/Veteriner Fakültesi/Fizyoloji Anabilim Dalı. 0000-0002-5600-8162 Yalçın, Murat AAG-6956-2021 57192959734
Keywords:	Angiogenesis Esterification HPLC Nanopharmaceutical technology Silylation Tetrac Integrin alpha-v-beta-3 Extracellular segment Crystal-structure Triiodothyronine Thyroxine Ligand Acid Pharmacology & pharmacy Chemistry
Issue Date:	15-Jun-2009
Publisher:	Pergamon-Elsevier Science
Citation:	Bridoux, A. vd. (2009). "Semisynthesis and pharmacological activities of tetrac analogs: Angiogenesis modulators". Bioorganic and Medicinal Chemistry Letters, 19(12), 3259-3263.
Abstract:	Novel Tetrac analogs were synthesized and then tested. Anti-angiogenesis efficacy was carried out using the Chick Chorioallantoic Membrane (CAM) model and the mouse matrigel model for angiogenesis. Pharmacological activities showed Tetrac can accommodate numerous modifications and maintain anti-angiogenesis activity.
URI:	https://doi.org/10.1016/j.bmcl.2009.04.094 https://www.sciencedirect.com/science/article/pii/S0960894X09006040 http://hdl.handle.net/11452/23162
ISSN:	0960-894X
Appears in Collections:	Scopus Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI